MedTrace Logo

Culturally-Targeted COVID-19 Communication and SARS-CoV-2 Antibody Testing Evaluation and Uptake

NCT04957082 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 666

Last updated 2024-06-28

Study results available
· View outcomes & findings →

Summary

This disparities-focused study seeks to evaluate communication strategies for better encouraging understanding and uptake of salivary SARS-CoV-2 antibody testing among African Americans residing in Flint, Michigan. This iteration will consider individuals recruited from the Flint Registry and assess willingness to participate in a drive-up saliva sample collection taking place at a central location in Flint, Michigan.

Conditions

  • SARS-CoV2 Infection

Interventions

BEHAVIORAL

Culturally Targeted SARS-CoV-2 Communication

SARS-CoV-2 video tutorial includes a one minute video based messaging adjunct meant to enact a culturally targeted framing of health information presented to African Americans.

BEHAVIORAL

General SARS-CoV-2 Communication

SARS-CoV-2 video tutorial is for general consumption and does not include culturally targeted information

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-04
Primary Completion
2022-12-19
Completion
2022-12-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04957082 on ClinicalTrials.gov